Use and effects of smoking cessation pharmacotherapies in respiratory disease

Smoking is common, and poses risks in adults with asthma, yet there is a paucity of literature regarding smoking cessation among these individuals, specifically pregnant people. This PhD will investigate the magnitude of smoking cessation pharmacotherapy use among adults with asthma in NSW, their effectiveness and safety for both adults and offspring. These research questions will be investigated using linked routinely collected administrative data, including hospital admission data, emergency department data, pharmaceutical dispensing data and death records.

Primary Supervisor: Dr Alys Havard
Joint Supervisor: Dr Annelies Robijn

Candidate requirements:

Masters or Honours in public health, epidemiology, pharmacoepidemiology, biostatistics or a related field

• Strong skills in quantitative data analysis, with experience using linked administrative data highly regarded
• Track record of publication of peer-reviewed scientific articles
• Excellent written and verbal communication skills

How to Apply

For more information about this project please contact Annelies Robijn (a.robijn@unsw.edu.au)